
    
      OBJECTIVES:

      I. To assess the prevalence of esophageal pathology (any esophageal abnormality,
      specifically: esophagitis, stricture/web, infections, neoplasms) as identified by
      esophagoscopy in patients with HNCA before and 3 months following primary radiation and/or
      chemotherapy.

      II. To assess the changes in self-reported dysphagia symptoms as measured by the Eating
      Assessment Tool.

      OUTLINE:

      Patients undergo transnasal esophagoscopy at baseline and 3 months following completion of
      radiation therapy and/or chemotherapy.
    
  